Agomelatine
CAS NO.: 138112-76-2
MF: C15H17NO2
EINECS NO.: 629-727-7
MF: C15H17NO2
EINECS NO.: 629-727-7
API223
Quantity
![]()

Agomelatine is indicated to treat major depressive episodes in adults.
Agomelatine, which is developed by the French Servier company, is the world's first melatonin receptors
MT1 and MT2 agonist class of antidepressants.
![]()
Agomelatine can be used as a novel drug for the treatment of depression.
Its mechanism of action is to achieve antidepressant effects by regulating melatonin and serotonin receptors.
In addition, it can also improve the quality of sleep, and has some help for patients suffering from insomnia.



